title: Progress lies in precision.
authors.affiliation: Sue Desmond-Hellmann is the chief executive officer of the Bill & Melinda Gates Foundation, Seattle, WA, USA, and a former president at Genentech, Inc., San Francisco, CA, USA.
authors.forename: Sue
authors.initials: S
authors.lastname: Desmond-Hellmann
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D005260:Female; D005582:Foundations; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007231:Infant, Newborn; D066087:Perinatal Death; D057285:Precision Medicine / Q000639:trends*; D011634:Public Health / Q000639:trends*
chemical_list: D044966:Anti-Retroviral Agents